Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jan 1;84(1):100–105. doi: 10.1054/bjoc.2000.1538

Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs

I F Tannock 1, C Lee 1
PMCID: PMC2363623  PMID: 11139321

Abstract

An increase in apoptotic cells may be observed after treatment with chemotherapy, and many authors have assumed that anti-cancer drugs kill cells by inducing apoptosis. The most relevant endpoint of cell death following treatment of tumour cells is loss of reproductive ability as measured by a colony-forming assay, since cells with limited reproductive potential cannot regenerate a tumour. We have therefore investigated the relationship between apoptosis and reproductive cell death following in vitro treatment of mammalian cell lines with anti-cancer drugs. Markers of apoptosis (DNA ladders, TUNEL assay) were evaluated at various times after treatment of Chinese Hamster Ovary (CHO) cells, human bladder cancer MGH-U1 cells, and a murine T-lymphocytic cell line (CTLL-2) with several anti-cancer drugs. These markers were found infrequently, despite the use of doses that cause loss of colony-forming ability, except in CTLL-2 cells. We also transfected and expressed the human pro-apoptotic gene bax and the anti-apoptotic gene bcl-2 in MGH-U1 cells and compared cell survival after drug treatment with that of control cells transfected with the vector alone. Expression of these genes had at most small effects to influence cell survival. We conclude that apoptotic mechanisms had at most a minor role in leading to reproductive death of MGH-U1 and CHO cells after chemotherapy. When apoptosis is observed following treatment with anti-cancer drugs it may be a secondary event which occurs in lethally-damaged cells, leading to their lysis, rather than a primary event that leads to loss of reproductive integrity. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: apoptosis, anti-cancer drugs, clonogenic survival

Full Text

The Full Text of this article is available as a PDF (111.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge D. R., Arends M. J., Radford I. R. Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response. Br J Cancer. 1995 Mar;71(3):571–577. doi: 10.1038/bjc.1995.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brezden C. B., McClelland R. A., Rauth A. M. Mechanism of the selective hypoxic cytotoxicity of 1-methyl-2-nitroimidazole. Biochem Pharmacol. 1994 Jul 19;48(2):361–370. doi: 10.1016/0006-2952(94)90108-2. [DOI] [PubMed] [Google Scholar]
  3. Brown J. M., Wouters B. G. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 1999 Apr 1;59(7):1391–1399. [PubMed] [Google Scholar]
  4. Chang F. L., Lai M. D. The relationship between p53 status and anticancer drugs-induced apoptosis in nine human bladder cancer cell lines. Anticancer Res. 2000 Jan-Feb;20(1A):351–355. [PubMed] [Google Scholar]
  5. Hu T., Miller C. M., Ridder G. M., Aardema M. J. Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res. 1999 May 3;426(1):51–62. doi: 10.1016/s0027-5107(99)00077-9. [DOI] [PubMed] [Google Scholar]
  6. Hu Z. B., Yang G. S., Li M., Miyamoto N., Minden M. D., McCulloch E. A. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. Leukemia. 1995 May;9(5):789–798. [PubMed] [Google Scholar]
  7. Kramer M. H., Hermans J., Parker J., Krol A. D., Kluin-Nelemans J. C., Haak H. L., van Groningen K., van Krieken J. H., de Jong D., Kluin P. M. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. J Clin Oncol. 1996 Jul;14(7):2131–2138. doi: 10.1200/JCO.1996.14.7.2131. [DOI] [PubMed] [Google Scholar]
  8. Kyprianou N., King E. D., Bradbury D., Rhee J. G. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer. 1997 Jan 27;70(3):341–348. doi: 10.1002/(sici)1097-0215(19970127)70:3<341::aid-ijc16>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  9. Lock R. B., Stribinskiene L. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res. 1996 Sep 1;56(17):4006–4012. [PubMed] [Google Scholar]
  10. Pereira H., Silva S., Julião R., Garcia P., Perpétua F. Prognostic markers for colorectal cancer: expression of P53 and BCL2. World J Surg. 1997 Feb;21(2):210–213. doi: 10.1007/s002689900218. [DOI] [PubMed] [Google Scholar]
  11. Roper P. R., Drewinko B. Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res. 1976 Jul;36(7 Pt 1):2182–2188. [PubMed] [Google Scholar]
  12. Sakakura C., Sweeney E. A., Shirahama T., Igarashi Y., Hakomori S., Nakatani H., Tsujimoto H., Imanishi T., Ohgaki M., Ohyama T. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer. 1996 Jul 3;67(1):101–105. doi: 10.1002/(SICI)1097-0215(19960703)67:1<101::AID-IJC17>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  13. Tai Y. T., Lee S., Niloff E., Weisman C., Strobel T., Cannistra S. A. BAX protein expression and clinical outcome in epithelial ovarian cancer. J Clin Oncol. 1998 Aug;16(8):2583–2590. doi: 10.1200/JCO.1998.16.8.2583. [DOI] [PubMed] [Google Scholar]
  14. Veronese S., Mauri F. A., Caffo O., Scaioli M., Aldovini D., Perrone G., Galligioni E., Doglioni C., Dalla Palma P., Barbareschi M. Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up. Int J Cancer. 1998 Feb 20;79(1):13–18. doi: 10.1002/(sici)1097-0215(19980220)79:1<13::aid-ijc3>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  15. Yin D. X., Schimke R. T. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res. 1995 Nov 1;55(21):4922–4928. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES